Shire Pharma Canada ULC ("Shire Canada") is a wholly owned subsidiary of
Shire plc, a global specialty biopharmaceutical company that works closely with
specialist physicians to develop and market medicines that improve the quality
of life for patients, their families and caregivers.
Shire Canada focuses on attention deficit hyperactivity disorder (ADHD), rare
diseases, as well as gastrointestinal and renal
In Canada, Shire is a proud member of Innovative Medecines Canada (previously
known as Rx&D) and of BIOTECanada.
Our Canadian offices are located in the Greater Montreal area, in Québec:
2250 Alfred-Nobel Blvd, Suite 500
Saint-Laurent, QC H4S 2C9
Tel: +1 514 787 2300
Fax: +1 514 787 2427